Parmax Pharma Ltd: New Promoters Take Control, Open Offer Launched

An open offer for Parmax Pharma Ltd has been initiated by Fedex Securities Private Limited, signalling a significant change in the company's ownership and management.

Reader Takeaway: New promoters take charge; ₹42.80 open offer price; existing promoters fully exit.

What just happened

Fedex Securities Private Limited has filed a public announcement for a mandatory open offer for Parmax Pharma Limited. This event signifies the exit of the current promoter group, comprising Alkesh Mahasukhlal Gopani, Vipul Mahasukhlal Gopani, and Pravina Mahasukh Gopani. Concurrently, Dhiren Chandulal Shah and Sunil Chinubhai Shah are set to become the new promoters, acquiring control of the company.

The open offer is for 23,46,250 shares at a price of ₹42.80 per share, amounting to a total consideration of ₹10.04 crore.

Why this matters

This development marks a complete transition in the company's leadership and shareholding structure. Shareholders are directly impacted by the open offer price and the departure of the existing promoter group. The acquisition of control by new entities suggests a potential shift in the company's strategic direction.

The backstory

The transaction is structured through multiple components. It includes a Share Purchase Agreement for ₹4.03 crore, a Preferential Issue of equity shares for ₹8.32 crore, and a Preferential Issue of warrants for ₹6.26 crore, all at varying prices. The open offer for ₹10.04 crore is a mandatory step following the change in control.

What changes now

Dhiren Chandulal Shah and Sunil Chinubhai Shah will assume the role of new promoters. The existing promoters are selling their entire stake. The acquirers have committed to maintaining the required 25% minimum public shareholding and do not intend to delist the company.

Risks to watch

Future dilution is a key concern, as the company is issuing 21,45,146 warrants convertible into equity shares within 18 months. A significant portion of these warrants (17,16,574) are for the acquirers and their associates. Investors must closely monitor the conversion of these warrants.

Peer comparison

No direct peer comparison is available from the filing.

Context metrics (time-bound)

• Open Offer Size: 23,46,250 Shares
• Open Offer Price: ₹42.80 per share
• Total Open Offer Consideration: ₹10.04 crore
• Preferential Issue (Equity) Price: ₹36.50 per share
• Preferential Issue (Warrants) Price: ₹36.50 per warrant
• Warrants to be issued: 21,45,146

What to track next

Investors should closely follow regulatory approvals for the transaction and the successful completion of the preferential issue. Compliance with the minimum public shareholding norms post-transaction will also be a critical factor to monitor.